Epharmix Announces Strategic Investment from UnityPoint HealthOctober 11, 2019 / Nueterra Capital Marketing
Nueterra Capital portfolio company Epharmix recently announced an investment from UnityPoint Health Ventures, the investment arm of health system Unity Point Health. Epharmix uses evidence-based check-ins to collect patient-reported symptoms and biometrics to engage patients and monitor chronic and behavioral health conditions. You can read the full article here.
Subscribe To Our Newsletter
Join our mailing list to receive the latest news and updates from Nueterra Capital.